88 related articles for article (PubMed ID: 12508654)
1. [Endothelin-1 expression and quantitative analysis in astrocytomas].
Li JM; Wu XL; Zhu QJ; Wang QJ
Ai Zheng; 2002 Oct; 21(10):1109-11. PubMed ID: 12508654
[TBL] [Abstract][Full Text] [Related]
2. The expression of thyroid hormone receptor isoforms in human astrocytomas.
Hwang SL; Lin CL; Lieu AS; Hwang YF; Howng SL; Hong YR; Chang DS; Lee KS
Surg Neurol; 2008 Dec; 70 Suppl 1():S1:4-8; discussion S1:8. PubMed ID: 18617237
[TBL] [Abstract][Full Text] [Related]
3. Upregulation of frizzled 9 in astrocytomas.
Zhang Z; Schittenhelm J; Guo K; Bühring HJ; Trautmann K; Meyermann R; Schluesener HJ
Neuropathol Appl Neurobiol; 2006 Dec; 32(6):615-24. PubMed ID: 17083476
[TBL] [Abstract][Full Text] [Related]
4. Increased expression of podoplanin in malignant astrocytic tumors as a novel molecular marker of malignant progression.
Mishima K; Kato Y; Kaneko MK; Nishikawa R; Hirose T; Matsutani M
Acta Neuropathol; 2006 May; 111(5):483-8. PubMed ID: 16596424
[TBL] [Abstract][Full Text] [Related]
5. [Correlation of hTERT expression to maspin and bFGF expression and their significance in glioma].
Wang DL; Wang YF; Shi GS; Huang H
Ai Zheng; 2007 Jun; 26(6):601-6. PubMed ID: 17562265
[TBL] [Abstract][Full Text] [Related]
6. [Study on endothelin-1 positive expression and quantitative analysis in lung cancer].
Yang X; Liu L; Qi H
Zhonghua Jie He He Hu Xi Za Zhi; 1998 Feb; 21(2):111-3. PubMed ID: 11263384
[TBL] [Abstract][Full Text] [Related]
7. MIB-1 labeling index in astrocytic tumors--a clinicopathologic study.
Neder L; Colli BO; Machado HR; Carlotti CG; Santos AC; Chimelli L
Clin Neuropathol; 2004; 23(6):262-70. PubMed ID: 15584210
[TBL] [Abstract][Full Text] [Related]
8. Low expression of p27 indicates a poor prognosis in patients with high-grade astrocytomas.
Kirla RM; Haapasalo HK; Kalimo H; Salminen EK
Cancer; 2003 Feb; 97(3):644-8. PubMed ID: 12548606
[TBL] [Abstract][Full Text] [Related]
9. Assessment and prognostic significance of mitotic index using the mitosis marker phospho-histone H3 in low and intermediate-grade infiltrating astrocytomas.
Colman H; Giannini C; Huang L; Gonzalez J; Hess K; Bruner J; Fuller G; Langford L; Pelloski C; Aaron J; Burger P; Aldape K
Am J Surg Pathol; 2006 May; 30(5):657-64. PubMed ID: 16699322
[TBL] [Abstract][Full Text] [Related]
10. Tenascin-C expression relates to clinicopathological features in pilocytic and diffuse astrocytomas.
Maris C; Rorive S; Sandras F; D'Haene N; Sadeghi N; Bièche I; Vidaud M; Decaestecker C; Salmon I
Neuropathol Appl Neurobiol; 2008 Jun; 34(3):316-29. PubMed ID: 17983425
[TBL] [Abstract][Full Text] [Related]
11. Expression of tenascin-C in various human brain tumors and its relevance for survival in patients with astrocytoma.
Leins A; Riva P; Lindstedt R; Davidoff MS; Mehraein P; Weis S
Cancer; 2003 Dec; 98(11):2430-9. PubMed ID: 14635078
[TBL] [Abstract][Full Text] [Related]
12. Analysis of interleukin (IL)-8 expression in human astrocytomas: associations with IL-6, cyclooxygenase-2, vascular endothelial growth factor, and microvessel morphometry.
Samaras V; Piperi C; Levidou G; Zisakis A; Kavantzas N; Themistocleous MS; Boviatsis EI; Barbatis C; Lea RW; Kalofoutis A; Korkolopoulou P
Hum Immunol; 2009 Jun; 70(6):391-7. PubMed ID: 19332096
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic and prognostic significance of cyclin A expression in low-grade astrocytomas: comparison with astrogliosis and high-grade tumours.
Hara A; Saegusa M; Ichinoe M; Okayasu I
J Clin Pathol; 2008 Mar; 61(3):287-92. PubMed ID: 18156430
[TBL] [Abstract][Full Text] [Related]
14. Pitfalls in the assessment of MGMT expression and in its correlation with survival in diffuse astrocytomas: proposal of a feasible immunohistochemical approach.
Capper D; Mittelbronn M; Meyermann R; Schittenhelm J
Acta Neuropathol; 2008 Feb; 115(2):249-59. PubMed ID: 17965865
[TBL] [Abstract][Full Text] [Related]
15. Podocalyxin expression in malignant astrocytic tumors.
Hayatsu N; Kaneko MK; Mishima K; Nishikawa R; Matsutani M; Price JE; Kato Y
Biochem Biophys Res Commun; 2008 Sep; 374(2):394-8. PubMed ID: 18639524
[TBL] [Abstract][Full Text] [Related]
16. [Immunohistochemical study of proliferation index of astrocytomas classified by new histopathological grading].
Takekawa Y; Sawada T; Sakurai I
Rinsho Byori; 1995 May; 43(5):483-6. PubMed ID: 7783368
[TBL] [Abstract][Full Text] [Related]
17. Clinical significance of sphingosine kinase-1 expression in human astrocytomas progression and overall patient survival.
Li J; Guan HY; Gong LY; Song LB; Zhang N; Wu J; Yuan J; Zheng YJ; Huang ZS; Li M
Clin Cancer Res; 2008 Nov; 14(21):6996-7003. PubMed ID: 18980995
[TBL] [Abstract][Full Text] [Related]
18. [Correlation between magnetic resonance diffusion weighted imaging and cell density in astrocytoma].
Chen J; Xia J; Zhou YC; Xia LM; Zhu WZ; Zou ML; Feng DY; Wang CY
Zhonghua Zhong Liu Za Zhi; 2005 May; 27(5):309-11. PubMed ID: 15996330
[TBL] [Abstract][Full Text] [Related]
19. Expression of endothelial nitric oxide synthase and vascular endothelial growth factor in association with neovascularization in human primary astrocytoma.
Pan JW; Zhan RY; Tong Y; Zhou YQ; Zhang M
J Zhejiang Univ Sci B; 2005 Jul; 6(7):693-8. PubMed ID: 15973775
[TBL] [Abstract][Full Text] [Related]
20. Increased expression of highly sulfated keratan sulfate synthesized in malignant astrocytic tumors.
Kato Y; Hayatsu N; Kaneko MK; Ogasawara S; Hamano T; Takahashi S; Nishikawa R; Matsutani M; Mishima K; Narimatsu H
Biochem Biophys Res Commun; 2008 May; 369(4):1041-6. PubMed ID: 18329383
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]